Compare Albemarle Corp. with Similar Stocks
Stock DNA
Specialty Chemicals
USD 21,193 Million (Small Cap)
7,040.00
NA
23.10%
0.16
1.68%
2.12
Revenue and Profits:
Net Sales:
1,308 Million
(Quarterly Results - Sep 2025)
Net Profit:
-148 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
90.68%
0%
90.68%
6 Months
146.0%
0%
146.0%
1 Year
104.49%
0%
104.49%
2 Years
47.62%
0%
47.62%
3 Years
-41.28%
0%
-41.28%
4 Years
-21.92%
0%
-21.92%
5 Years
8.88%
0%
8.88%
Albemarle Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.15%
EBIT Growth (5y)
-182.59%
EBIT to Interest (avg)
8.81
Debt to EBITDA (avg)
4.11
Net Debt to Equity (avg)
0.19
Sales to Capital Employed (avg)
0.52
Tax Ratio
5.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
9.46%
ROE (avg)
12.35%
Valuation key factors
Factor
Value
P/E Ratio
7040
Industry P/E
Price to Book Value
0.70
EV to EBIT
-19.14
EV to EBITDA
56.37
EV to Capital Employed
0.75
EV to Sales
1.76
PEG Ratio
NA
Dividend Yield
269.21%
ROCE (Latest)
-3.92%
ROE (Latest)
0.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 125 Schemes (59.54%)
Foreign Institutions
Held by 393 Foreign Institutions (18.57%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
1,307.80
1,330.00
-1.67%
Operating Profit (PBDIT) excl Other Income
134.00
222.50
-39.78%
Interest
51.00
49.90
2.20%
Exceptional Items
-197.20
-5.70
-3,359.65%
Consolidate Net Profit
-147.90
35.20
-520.17%
Operating Profit Margin (Excl OI)
-23.30%
40.40%
-6.37%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.67% vs 23.50% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -520.17% vs -28.60% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
5,377.50
9,617.20
-44.08%
Operating Profit (PBDIT) excl Other Income
-39.80
671.10
-105.93%
Interest
165.60
116.10
42.64%
Exceptional Items
-1,185.20
171.30
-791.89%
Consolidate Net Profit
-1,135.50
1,670.50
-167.97%
Operating Profit Margin (Excl OI)
-117.30%
25.10%
-14.24%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -44.08% vs 31.38% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -167.97% vs -40.66% in Dec 2023
About Albemarle Corp. 
Albemarle Corp.
Specialty Chemicals
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions. The bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Company serves various end markets, including petroleum refining, consumer electronics, energy storage, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. As of December 31, 2016, the Company and its joint ventures operated 31 production and research and development (R&D) facilities, as well as a number of administrative and sales offices, around the world.
Company Coordinates 
Company Details
4250 Congress St Ste 900 , CHARLOTTE NC : 28209-4615
Registrar Details






